|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.50 BDT | -0.95% |
|
-3.36% | +17.77% |
| Market Cap | 17.44B 141M 124M 115M 106M 199M 13.63B 202M 1.37B 536M 6.67B 530M 519M 23.04B | P/E 2024 |
5.9x | P/E 2025 | 6.29x |
|---|---|---|---|---|---|
| Enterprise Value | 40.31B 327M 286M 266M 244M 460M 31.52B 467M 3.17B 1.24B 15.42B 1.23B 1.2B 53.28B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 1.06x |
| Free-Float |
55.88% | Yield 2024 |
5.11% | Yield 2025 | 4.85% |
| 1 day | -0.95% | ||
| 1 week | -3.36% | ||
| Current month | +1.33% | ||
| 1 month | +3.99% | ||
| 3 months | +8.87% | ||
| 6 months | +13.45% | ||
| Current year | +17.77% |
| 1 week | 83.1 | 86.4 | |
| 1 month | 80.2 | 88.7 | |
| Current year | 70.6 | 88.7 | |
| 1 year | 68.6 | 88.7 | |
| 3 years | 62.6 | 94.5 | |
| 5 years | 62.6 | 117.7 | |
| 10 years | 54.2 | 122.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1995-09-29 | |
| Director of Finance/CFO | - | - | |
Asad Shamsuddin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 82 | 1975-03-16 | |
| Director/Board Member | 76 | 1981-04-14 | |
| Chairman | 69 | 2018-09-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.95% | -3.36% | +5.96% | -2.00% | 143M | ||
| -1.05% | +0.55% | +49.79% | +151.71% | 1,037B | ||
| +2.00% | +3.49% | +52.22% | +50.20% | 615B | ||
| -1.09% | +3.76% | +35.37% | +76.22% | 448B | ||
| +2.17% | +2.93% | +30.62% | +24.79% | 326B | ||
| -1.01% | +0.83% | +33.46% | +36.87% | 293B | ||
| -1.54% | -0.60% | +17.59% | +16.44% | 264B | ||
| -1.68% | -6.18% | -28.85% | -42.72% | 216B | ||
| -0.05% | +2.16% | +19.75% | +55.89% | 198B | ||
| +0.05% | -1.03% | +18.31% | +61.63% | 162B | ||
| Average | -0.40% | +0.80% | +23.42% | +42.90% | 355.76B | |
| Weighted average by Cap. | -0.46% | +1.47% | +35.04% | +72.34% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 31.93B 259M 227M 210M 193M 364M 24.97B 370M 2.51B 981M 12.22B 971M 950M 42.2B | 35.94B 291M 255M 237M 218M 410M 28.1B 416M 2.82B 1.1B 13.75B 1.09B 1.07B 47.5B |
| Net income | 2.46B 19.9M 17.44M 16.19M 14.88M 28.03M 1.92B 28.44M 193M 75.48M 940M 74.71M 73.1M 3.25B | 2.43B 19.68M 17.24M 16.01M 14.71M 27.72M 1.9B 28.13M 191M 74.64M 929M 73.87M 72.28M 3.21B |
| Net Debt | 22.18B 180M 157M 146M 134M 253M 17.34B 257M 1.74B 682M 8.49B 675M 660M 29.31B | 22.87B 185M 162M 151M 139M 261M 17.88B 265M 1.8B 703M 8.75B 696M 681M 30.23B |
Employees
9,025
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-22 | BDT 83.50 | -0.95% | 669,961 |
| 26-07-21 | BDT 84.30 | 0.00% | 596,624 |
| 26-07-20 | BDT 84.30 | +0.36% | 357,746 |
| 26-07-19 | BDT 84.00 | -1.52% | 749,927 |
| 26-07-16 | BDT 85.30 | -1.27% | 920,682 |
- Stock Market
- Stocks
- ACMELAB Stock
Select your edition
All financial news and data tailored to specific country editions
















